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We describe anew fluorescence imaging device for clinical cancer photodetection in hollow organs 
in which the tumor/normal tissue contrast is derived from the fluorescence lifetime of endogenous 
or exogenous fluorochromes. This fluorescence lifetime contrast gives information about he phys- 
icochemical properties of the environment which are different between ormal and certain diseased 
tissues. The excitation light from a CW laser is modulated in amplitude at a radio frequency by 
an electrooptical modulator and delivered by an optical fiber through an endoscope tothe hollow 
organ. The image of the tissue collected by the endoscope is separated in two spectral windows, 
one being the backscattered xcitation light and the other the fluorescence of the fluorochrome. 
Each image is then focused on the photocathode of image intensifiers (II) whose optical gain is 
modulated at the same frequency as the excitation i tensity, resulting in homodyne phase-sensitive 
images. By acquiring stationary phase-sensitive frames at different phases between the excitation 
and the detection, it is possible to calculate in quasi-real time the apparent fluorescence lifetime 
of the corresponding tissue region for each pixel. A result obtained by investigating the endogenous 
fluorochromes present in the mucous membrane of an excised human bladder is presented to 
illustrate this method and most of the optical parameters which are of major importance for this 
photodetection modality have been evaluated. 
KEY WORDS: Light-induced fluorescence; frequency domain; photodetection; cancer; fluorescence lifetime 
imaging; endoscopy; optical biopsy. 
INTRODUCTION 
Because an important portion of the advanced-stage 
cancers is difficult to treat effectively, it is important to 
detect hem at an early stage3 t)Many invasive cancers 
are preceded by alterations, uch as dysplasia, or carci- 
noma in situ (CIS)52~) However, for most of these early 
lesions, there are no effective methods to detect hese 
stages of the disease. Most cancers originate in superfi- 
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cial tissues (skin cancer) or in the tissues lining the body 
cavities or tubes such as bronchial cancers of the lung 
and cancers of the esophagus, tomach, colon, bladder, 
and female reproductive organs. Furthermore, the use of 
light-induced fluorescence (LIF) spectroscopy originated 
with the development of medical endoscopes by numer- 
ous investigators as a potentially powerful method of 
detecting and localizing malignant tumors. 
Tissue characterization using LIF spectroscopy can 
be divided into two categories. The first is based on the 
detection of the native tissue fluorescence (autofluoresc- 
ence), which induces an optical contrast between the le- 
sion and the surrounding normal tissues. Among other 
things, tissues are made up of proteins, nucleic acids, 
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lipids, and water with fluorescing and nonfluorescing 
chromophores. Many tissues are known to fluoresce in 
the UV and visible part of the spectrum. r The groups 
of Alfano, ~6) Lohmann,CT) and Yuanlong as) conducted pi- 
oneering studies in this field which, to some extent, gave 
rise to the increasing number of papers on the autoflu- 
orescence excitation and emission spectra of human and 
animal tissues performed in vitro and in vivo. OJS) 
The second approach concerning the clinical use of 
LIF spectroscopy for detecting and localizing malignant 
tumors is based on the administration of a fluorescent 
drug such as hematoporphyrin derivative (HPD) or its 
somewhat purified form Photofrin II, cl6,23) ~-aminolevu- 
linic acid-induced protoporphyrin IX (ALA-PPIX), t24,27) 
tetra(meta-hydroxyphenyl)chlorin (mTHPC), ~28) and 
fluorochromes coupled to monoclonal antibodies, tzg) 
Such "drugs" tend to localize to some extent selectively 
in certain tumors after intravenous injection. The region 
where a superficial cancer is suspected is then irradiated 
with light at a wavelength at which more dye fluores- 
cence is induced from the tumor, with its relatively high 
drug concentration, than from the dye-deficient sur- 
rounding normal tissue. 
The interest in studying the time-resolved fluores- 
cence spectroscopy of exogenous and endogenous fluor- 
ochromes to characterize biological tissues is connected 
with two major reasons. 
(1) The optical contrast between the lesion and the 
surrounding normal tissue is a key parameter 
limiting the performance of cancer LIF photo- 
detection. This contrast is unfortunately de- 
graded frequently when a steady-state LIF 
technique is used due to, among other things, 
tissue autofluorescence in both tumor and nor- 
mal tissue. As the above-mentioned clinically 
used exogenous dyes have fluorescence life- 
times which are different from that of the en- 
dogenous fluorochromes, better discrimination 
(improved contrast) between these two dyes 
can be obtained in principle using time-re- 
solved fluorescence imaging. 
(2) Several endogenous and exogenous fluoro- 
chromes are more or less sensitive to their local 
environment. According to the literature, some 
microenvironmental p rameters differ between 
normal tissues and some neoplastic lesions. 
Among these, one might mention the pH,C30) the 
DNA and/or RNA content,O~) the cell mem- 
brane permeability, which can influence the ac- 
cess of the fluorochrome to certain 
m~crocompartments such as the nucleus,C32.33) 
and the enzymatic activity.t34as) A  the fluores- 
cence lifetime is very sensitive to small pertur- 
bations in the environment ofthe fluorochrome, 
it is of interest o evaluate the performance of 
time-resolved LIF spectroscopy for tissue char- 
acterization based on the physicochemical 
properties of the local environment. More im- 
portant is the fact that, in principle, environ- 
mentally sensitive dyes do not require selective 
localization in a tumor for effective marking. 
Fluorescence lifetimes can be determined from the 
inverse slope of the exponential decay of the light inten- 
sity following pulsed excitation. This is the so-called 
"time-domain" approach. The corresponding approach 
for the imaging of fluorescence lifetime consists of pixel- 
by-pixel scanning and time-correlated single-photon 
counting3 TM Such measurements require a considerable 
amount of time, and it may not be practical to produce 
high-resolution and/or real-time images. Other laborato- 
ries have created time-decay contrasts using time gating 
of the long-lived fluorescence. ~37~s~ However, these meth- 
ods provide information only on the presence of the de- 
layed emission. Moreover, on-gating of delayed emission 
does not appear to have contrast opportunities such as 
particularly lifetime-based contrast and selective obser- 
vation of either short or long components of the fluores- 
cence decay. Obviously, the technique of pulsed image 
intensifier gating is restricted to fluorescence lifetimes that 
differ by at least one order of magnitude to allow for an 
efficient lifetime-based selective signal suppression. 
Another approach, which avoids most of the above 
mentioned rawbacks of the time-domain approach, con- 
sists of using "frequency-domain" fluorescence lifetime 
imaging (FLIM) techniques as described below. 
One of the novelties of our implementation of this 
method is that fluorescence and reference images are 
taken simultaneously and treated in quasi-real time. The 
main advantage of such simultaneous measurement com- 
pared to sequential detection is that exactly the same 
area is imaged in the different spectral bands indepen- 
dently of the scene movements. Moreover, the device 
described below allows for an immediate observation of
the endoscopic area under white light illumination dur- 
ing fluorescence detection to localize the origin of the 
fluorescence signals of interest. 
EXPERIMENTAL 
Operating Principle of the FLIM Apparatus 
The basic principle of "frequency-domain" FLIM 
has been described by Lakowicz et aL O9,41) This group 
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Fig. 1. Principle and signal processing of the frequency-domain fluorescence lifetime imaging apparatus. Three reference (backscattering) and three 
fluorescence images are detected simultaneously for three different phases from the fluorescence excitation. Detection of this type enables deter- 
mination of the phase and modulation of both images for each pixeI. The fluorescence lifetime is then deduced from the phase difference and the 
modulation ratio for each pixel at the video frequency. 
essentially applied this technique in the context of flu- 
orescence microscopy experiments. 
Briefly, the principle of this approach consists of 
measuring the fluorescence lifetimes or decay times -r by 
the phase method, in which the sample is illuminated 
with fluorescence excitation light modulated at a radio 
frequency to. The basic idea is to observe the fluores- 
cence image with an image intensifier (II), whose optical 
gain is modulated at the same frequency, resulting i  
homodyne phase-sensitive images. Detection of this type 
will preserve the decay time information, as the two- 
dimensional output signal at the position 7 in the image 
plane depends onthe phase angle difference between the 
fluorescence emission and the gain modulation of the II. 
The phase shift A0 between the excitation light and 
the fluorescence and/or the modulation ratio M [  = 
(AC/DC components of the fluorescence)/(AC/DC com- 
ponents of the excitation)] enables (see Fig. I) the value 
of this lifetime in the case of a monoexponential decay 
to be obtained. These two parameters are related to the 
fluorescence lifetime by 
a0 ) 
"r(-F) = tan-  (1) 
to 
"r(7) =l_to ~/~/~7) 1 (2) 
In the case of multiexponential decays, the values 
of-r obtained with Eqs. (1) and (2) are generally not 
identical. 
It is not possible to determine a fluorescence life- 
time from a single phase-sensitive image. Various ap- 
proaches, based on the detection of fluorescence images 
at two or more phase shifts, have been proposed by Lak- 
owicz et al. to measure the fluorescence lifetime, o9) 
The approach we are using consists of determining 
the phase angle and/or the modulation at each point in 
the image by examining the detector phase-angle de- 
pendence of the image intensity for three phase hifts of 
the gain-modulation signal. This approach reduces ev- 
eral artifacts generated by the methods based on the de- 
tection at two phases only. 
As presented in Fig. 1, two gain-modulated image 
intensifiers are used in our experimental setup. One of 
them (II 1) detects the tissue fluorescence, whereas the 
other one (II 2) detects the backscattered fluorescence 
excitation light. The reference value of these phase angle 
(OR) and modulation (mR) are obtained with II 2, whereas 
II 1 measures the fluorescence phase (OF) and modulation 
(rnF). These stationary phase-sensitive images are col- 
lected using two CCD cameras, digitized, and manipu- 
lated with a mathematical operator in real time 
(quasi-video frequency) to determine the absolute phase 
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and modulation of each pixel. A second mathematical 
operator calculates the phase difference (A0) and/or 
modulation ratio (M) between the two images eries, as 
well as the value of "r. 
The resulting image therefore consists of pixels 
whose value corresponds to the fluorescence lifetime 
only. Hence, for "small" modulation frequencies (less 
than 5 GHz), the intensity of this lifetime image no 
longer depends on the fluorochrome concentration, ex- 
citation light intensity (which is quite heterogeneous in 
an endoscopic ontext), tissue-endoscope distance, and 
fluorochrome photobleaching (as long as the photoprod- 
ucts are not fluorescing). This lifetime image is finally 
combined with the corresponding color image obtained 
during white-light illumination of the endoscopic field. 
An advantage of the experimental method proposed 
here is that pixel-to-pixel scanning is not required to 
obtain the fluorescence lifetime image, as the informa- 
tion from all pixels is obtained at the same time by the 
CCD. 
Design and Characterization of the FLIM 
Apparatus 
The major factor degrading the endoscopic detect- 
ability of small tumors is either low signal levels re- 
sulting in. high image noise or insufficient contrast 
between tumor and surrounding normal tissue. Thus 
contrast, noise and, to a lesser extent, image sharpness 
are key parameters in early cancer detection using a flu- 
orescence imaging technique. The typical surface of an 
early-stage squamous cell carcinoma in the tracheobron- 
chial tree, the esophagus, orthe upper aerodigestive tract 
is of the order of 1 cm 2 at the time of detection. (23) Thus, 
at a typical observation distance, such a lesion occupies 
a significant portion of the field of view. The resolution 
of most standard medical endoscopes, image intensifiers, 
and CCD cameras is therefore sufficient for detecting 
such lesions. Therefore, when designing such an appa- 
ratus, the focus is on the reduction of noise and contrast 
enhancement of the tumor image. 
Noise is due mainly to photon statistics (shot noise) 
in the context of such experiments as discussed below. 
This noise can therefore be reduced by increasing the 
number of detected photons. For a given apparatus, de- 
tection geometry, tissue optics, and tumor marker, this 
can be done either by increasing the fluorescence exci- 
tation light intensity or by increasing the detection pe- 
riod. The former is limited by the dye photobleaching 
and the latter by loss of image sharpness when moving 
the endoscope. Other factors that might limit the use of 
high light intensity are thermal effects in the tissue. 
Under our conditions, the excitation light intensity 
is typically of the order of 50 mW/cm 2 at the tissue 
surface. Increasing the detection period to decrease the 
noise and/or to perform the calculation between the dif- 
ferent images is limited by the movement of the scene, 
i.e., integrating or calculation periods that are too tong 
would cause the image to streak and hence its quality to 
decrease. The frequency of intensity fluctuations corre- 
sponding to the maximum of the human eye temporal 
contrast sensitivity is between 5 and 10 Hz at the lu- 
minosity of conventional TV monitorsJ 42) Thus we 
found that the upper limit for time integration is of the 
order of 200 ms for a lifetime-reconstructed image, 
which corresponds to five consecutive PAL video 
frames. 
The Endoscopes 
In general we use standard medical rigid (Storz) 
and flexible (Olympus) endoscopes. Unfortunately, such 
endoscopes are not optimal for cancer photodetection, as 
the effective diameter of the objective which captures 
the light is small (typical diameter, 300 ~tm). This small 
diameter is due to the presence of biopsy, inflation, 
and/or suction channels and to their broad (typically 75 ~ )
field of view. Typically, if 20 mm is between the distal 
end of the endoscope and the cancer, the probability for 
the light emitted by the tissue to enter the objective is 
around 10-4! Furthermore, the imaging light guide flu- 
oresces when excitation light is reflected back to the ob- 
jective from the surface being inspected. Thus, at 
particular surface orientations, a strong specular eflec- 
tion may induce degradation of both the fluorescence 
and the reference images. 
For the time being, we have designed our apparatus 
to be compatible with most standard endoscopes avail- 
able which deliver images of widely varying diameters 
and with different apertures. 
Light Sources and Illumination Optics 
The fluorescence excitation light sotur~ presented in 
Fig. 2 is a continuous-wave argon ion pumped ye laser 
system (Coh~nt, Palo Alto, CA; Ianova 100 + CR599). 
Such a tunable device provides more than 500 mW be- 
tween 390 and 950 nm if different spectral configurations 
(dyes, mirrors) are used. Moreover, the argon ion laser 
itself can be used in the "mid-UV" (334-, 351-, 364-nm) 
or "deep-UV" (275-, 305-nm) modes if shorter wave- 
lengths are required. This laser beam is then modulated in 
intensity at a radio frequency by a tunable (1- to 350-MHz) 
Pockels cell (Quantum Technology, Lake Mary, FL; 
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Fig. 2. Experimental setup of the frequency-domain FLIM apparatus 
for endoscopic t ssue characterization. 
300- to 700-nm coated K.DP crystal) combined with a 
polarizer. This Pockels cell is operated by an amplified 
(Quantum Technology; T pe 3500 amplifier) frequency 
generator (Hewlett Packard HP 8648B). 
Obturation of the modulated laser beam is achieved 
by a rotating optical chopper controlled by a central 
clock. Such an obturation is required by the fact that our 
apparatus alternates between o modes of observation. 
The first one consists of illuminating the endoscopic 
scene with white light and acquiring the normal endo- 
scopic color image. In the second mode, laser excitation 
only is performed and the fluorescence and backscattered 
images are recorded simultaneously at three phases (sep- 
arated by 120 ~ between 0 and 360 ~ from the laser mod- 
ulation. In this second mode, the laser beam is coupled 
into a 200-p.m-core diameter quartz optical fiber to il- 
luminate the endoscopic site. 
The white-light source of our apparatus is a 300-W 
xenon lamp (Storz, Tuttlingen, Germany; Type 487B). 
An optical chopper controlled by the central timing con- 
troller switches off this white light during observation 
of the endoscopic field in the fluorescence mode. The 
transition time is about 2 ms, which enables alternation 
between these two modes at video frequency. The light 
provided by this white-light source is then coupled into 
the illumination optics of the endoscope. 
Detection Optics, Spectral Design, and Detectors 
The dye fluorescence, excitation backscattered 
light, and tissue autofluorescence i  one mode and the 
color image in the other mode are collected by the en- 
doscope objective. At the ocular end of the endoscope a 
beamsplitter cube is used to transmit 10% of the light 
for visual observation f the white-light image (cf. Fig. 
2). The other 90% is reflected toward a Storz articulated 
optical arm which is quite flexible and transmits 50% at 
630 nm. It consists in five rigid segments with Hopkins 
lenses. The quality of the image transmitted is superior 
to that of a fiberscope. The latter has a typical transmis- 
sion of 15% at this wavelength. The ocular at the end 
of the articulated arm is inserted into a black box which 
contains further optics, both gain-modulated image in- 
tensifiers, and the JVC (Model TK 1270 E) video color 
CCD camera. This ocular furnishes a divergent beam 
which varies from one endoscope to another and attains 
at most 15 ~ with a pupil of maximum 2-mm diameter. 
A photographic lens (Nikon f = 50 mm; aperture, 1.8) 
images this pupil on the reflecting chopper, which either 
lets the fluorescent a d backscattered images pass or re- 
flects the white-light image toward the video color cam- 
era. This chopper is also controlled by the central clock. 
The focusing on the reflective chopper is necessary to 
keep the dead time to a minimum (-1 ms) between the 
two modes. A dichroic mirror separates the spectral do- 
mains corresponding to the dye fluorescence and the ex- 
citation light. Another bandpass filter is placed in front 
of the image intensifier, which amplifies the dye fluo- 
rescence image, whereas a narrow bandpass filter is 
placed in front of the other image intensifier to detect 
the backscattered excitation light only. 
The zoom lenses (Fujinon H6XI 1.5B-MDM21) are 
necessary to make the apparatus compatible with many 
types of endoscopes. For instance, the size of the en- 
doscopic image may vary by as much as a factor f 3 
according to the type of endoscope used. More impor- 
tantly, however, if one decreases the size of an image 
on the intensifier, the intensity per pixel increases, and 
the signal-to-noise ratio is improved. The consequent 
loss of resolution can be tolerated easily under these con- 
ditions. Proximity focused image intensifiers are the only 
electrooptical devices which can be used in the context 
of these experiments due to the weak fluorescence yield 
of the fluorochromes investigated, the small collection 
efficiency of the endoscope objective, and the necessity 
to use imaging detectors the optical gain of which can 
be modulated atradio frequencies. These two-stage, fast- 
gated image intensifiers (Hamamatsu V5548MOD) have 
a typical maximum gain of 15,000 candela/mVlux. Their 
"multialkali" photocathode is sensitive between 180 
and 820 nm. The output of their phosphorescent screen 
(Type P20; kM~x = 550 rim) is coupled to a [739 (H) 
• 509 (V)-pixel] black-and-white CCD camera (Ha- 
mamatsu C 5985-10) with relay lenses (Hamamatsu 
A2098). The modulation of the optical gain of the image 
intensifiers is performed by changing the voltage be- 
tween their photocathodes and the input of their micro- 
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Fig. 3. Electronic diagram of the frequency-domain FLIM apparatus. 
channel plate. This voltage is controlled by a frequency 
generator (Hewlett Packard HP 8657B) which is 
"phase-locked" with the frequency generator control- 
ling the Pockels cell. A 12-bit phase shifter (Merrimac, 
West Caldwell, NJ; PLB-3B-10B) controlled by the 
computer is placed on the 10-MHz reference signal to 
change the phase of the HP 8657B frequency generator 
(see Fig. 2). 
The overall transmission at 630 nm for this optical 
setup is 20% if a Storz 0* esophagoscope is used. This 
transmission concerns all the optical components located 
between the endoscope objective and the photocathode 
of the image intensifier. 
Signal Processing and Electronic Design 
The acquisition and signal processing of the fluo- 
rescence and backscattered images are performed sepa- 
rately (Fig. 3). An image is recorded by the CCD for 
each phase shift (three in our case) between the fluores- 
cence excitation and the II gain modulation as presented 
in Fig. 1. The integration time for each of these frames 
can be set from 40 ms to 1 s. The images are then trans- 
ferred to a frame grabber as a standard video signal 
(Comit6 Cousultatif International de Radio-communica- 
tion, CCIR). After digitization (8 bits) in the frame grab- 
ber, the images are stored in a video memory (buffer). 
These buffers (three per channel) are refreshed sequen- 
tiaUy. Therefore, one given memory always stores an 
image acquired with the same phase shift. After each 
acquisition, the three buffers are scanned simultane- 
ously. For each pixel, the 24 bits (3 • 8 bits) are trans- 
ferred to a fast programmable "fitting" operator 
(look-up table) which contains preprogrammed com- 
puted values of the phase and/or modulation. As the two 
channels are synchronized, the output of the two look- 
up tables concern the same pixel at a given time. These 
two values are then transferred to the mathematical op- 
erator (2 • 8-bit look-up table). It calculates the appar- 
ent fluorescence lifetime of the corresponding pixels 
from these two values and stores the result in a buffer. 
For calculation of the fluorescence lifetime based on the 
phase shift, the operation consists in subtracting the 
phase of the reference image from the fluorescence im- 
age and applying expression (1). Similarly, the fluores- 
cence lifetime can also be obtained from the modulation. 
It consists of calculating the relative demodulation (Fig. 
1) and applying formula (2). Once the whole image is 
completed, it is converted back to an analog video signal 
(CCIR) and, finally, overlaid on the color image (Fig. 
2). In addition, both the result and the color images can 
be stored digitally on a hard disk (PC or external) or 
analogically on video recorders. 
The principal difficulty is the synchronization be- 
tween all electronic devices and the mechanical om- 
ponents (laser, white light, and reflecting choppers). This 
synchronization is based on the video signal (clock of 
one of the CCD) for the analog part of the circuitry 
(including the analog-to-digital conversion) and by the 
CPU for the digital part. One of the CCD, that of the 
backscattered image channel as in Fig. 3, synchronizes 
the other so that the two images are recorded at the same 
time. The same synchronization signal is used by the 
frame grabbers. When the image is fully digitized, the 
CPU transfers it to the proper video buffer. During the 
acquisition of the next frame, the CPU scans the content 
of the 3 + 3 buffers. The outputs of the look-up tables 
are updated for each new address in 25 ns (static-RAM). 
The CPU triggers the beginning of the analog conversion 
to a CCIR signal when the stored image in the output 
buffer is completed. The three choppers are also con- 
trolled by the CPU via a timing controller card which 
also controls the phase shifter. 
RESULTS AND DISCUSSION 
Our FLIM apparatus was initially evaluated in vitro 
using diluted fluorochromes with known fluorescence 
lifetimes from the literature. (43) Rhodamine 6G (3 ~tg/ml, 
'r = 6 ns, kEM = 560 rim) and acridine orange (10 gg/ml, 
"r = 2 ns, k~ = 530 rim) were dissolved in water for 
this purpose and their fluorescence was induced with 
green (514 nm) light of the argon ion laser modulated 
at 64 MHz. The lifetimes measured with our apparatus 
using both the phase shift and the modulation change 
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Fig. 4. Fluorescence lifetime image obtained with an opened, excised human bladder. The color of the pixel indicates the fluorescence lifetime, 
from 0 ns (deep blue) to 5 ns (red). The area located in the upper ight comer fluoresces with a lifetime of about 0.5 ns (blue), whereas the lower 
left area exhibits a longer lifetime of about 2.5 ns (green). The complete tissue sample has been characterized by serial histological sectioning. The 
short lifetime corresponded to ulceration of the mucous membrane, whereas the other part was normal urothelium. See the text for more information 
concerning the detection conditions. 
were consistent with the predicted values of these life- 
times. 
Preliminary, on-bench experiments were performed 
on a freshly excised human bladder. This bladder was 
opened after resection and examined by our FLIM ap- 
paratus. The fluorescence of the endogenous fluoro- 
chromes was also induced with green (514-nm) light. 
This wavelength, according to the literature, corresponds 
to the absorption of molecules of the flavin molecule 
family. (4,5~ The illumination i tensity of this tissue sam- 
ple was 1 mW/cm 2. The filter used to reject he fluores- 
cence excitation light was a longpass k > 550-nm filter 
and the modulation frequency was 40 MHz. Figure 4 
shows the image of the effective fluorescence lifetime as 
measured on the basis of the phase-shift. The pixel hue 
gives the fluorescence lifetime. The area located in the 
upper ight comer fluoresces with a lifetime of about 0.5 
ns (blue area in Fig. 4), whereas the lower left area ex- 
hibits a longer lifetime of about 2.5 ns (green area in 
Fig. 4). The complete tissue sample has been character- 
ized by serial histological sectioning. The short lifetime 
corresponded to ulceration of the mucous membrane, 
whereas the other part was normal urothelium. Also, the 
short fluorescence lifetime corresponded to a strong flu- 
orescence mission. Several specular eflections which 
induced saturation are clearly visible in this lifetime im- 
age (white spots). These saturations were detected by the 
reference camera. It is unfortunately impossible to elim- 
inate such artifacts using a standard optical filtration 
method. One approach consists of assuming that the 
phase and modulation reference, usually given by the 
reference image, is uniform over the entire field of view. 
This assumption is valid as long as Ad << 2rrc/to, 
where c is the velocity of light and Ad is the maximal 
distance difference between the distal end of the endo- 
scope and various points of the field of view. Under our 
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conditions, this method is feasible as long as the mod- 
ulation frequency v = co/2"rr is smaller than typically 50 
MHz. Hence, the investigation of finorochromes with a 
lifetime >5 ns using the FLIM apparatus can be per- 
formed with one image intensifier only, the reference 
being detected by a simple "point" detector. 
It can be shown that the limitation of such imaging 
devices based on the tissue autofluorescence is essen- 
tially due to the shot noise. It is not a straightforward. 
matter to determine the optimal approach which would 
enable the effect of this noise on the final result (i.e., the 
value of the fluorescence lifetime) to be minimized. Var- 
ious approaches, based on the detection of fluorescence 
frames at two or more phases, have been proposed by 
Lakowicz et al. to induce a contrast based on the fluo- 
rescence lifetime. (39) It has been suggested that the min- 
imum number of frames necessary to resolve any 
monoexponential decay is three, which is consistent with 
the fact that the number of parameters tobe determined 
is also three (i.e., the average amplitude, modulation, 
and phase; the frequency isknown). With noise, the sine 
wave calculation is not unique, i.e., different acquisition 
of the same fluorescence will lead to sets of different 
lifetimes. The number of frames has to be chosen to 
minimize this distribution. On the one hand, if the num- 
ber of frames is increased, the fitting is more precise 
(increase of the redundancy). On the other hand, increas- 
ing the number of frames will reduce the fluorescence 
acquisition time per frame and therefore will decrease 
the signal-to-noise ratio. The results of an analytical 
study and computer simulation presented elsewhere (44) 
have shown that the effect of the shot noise on fluores- 
cence lifetime images is not dependent on the number 
of frames for a given illumination intensity and total 
acquisition time. This result is of major importance, as 
it indicates that lifetime recovery is possible and optimal 
from three 8-bif images processed in real time using a 
look-up table or a fast operator. 
The study described in the above-mentioned r fer- 
ence has also shown that, for a given excitation fre- 
quency, the effect of the shot noise on the lifetime image 
is smaller with phase shift- than with demodulation- 
based measurements forfluorescence lifetimes which are 
smaller than 1/co. For fluorescence lifetimes which are 
longer than 1/co, the situation is inverted, i.e., demodu- 
lation-based measurements give better results. These 
simulation and calculation results were verified for dif- 
ferent modulation frequencies with the tissue samples 
described above (results not shown here). 
These tests on a freshly excised human bladder en- 
abled us to evaluate the optical parameters specific to 
this type of photodetection. As the spectral CCD detec- 
tor sensitivity (0.15 mJ/cm 2 per frame at 550 nm to ob- 
tain saturation), the CCD accumulation time (100 ms) 
per frame and the typical gain of the image intensifiers 
(103 W/cm2/W/cm 2)were known, it is possible to deter- 
mine the illumination of the fluorescence image inten- 
sifier's photocathode. This illumination, due to the tissue 
autofinorescence, is of the order of 10 -s W/cm 2 if the 
normal bladder wall is observed from a distance of 20 
mm under typical green light illumination intensity (10 
mW/cm 2 at 514 nm). Such illumination of the photo- 
cathode corresponds to 10,000 photons or to 1000 pho- 
toelectrons per pixel and per frame (photocathode 
quantum efficiency ~ 10%). Under these conditions, we 
calculated that the resulting standard eviation is about 
1 ns for a lifetime of 5 ns measured at 32 MHz. 
As the diameter of the endoscopic image on the 
image intensifier's photocathode (3 ram), the tissue il- 
lumination (10 mW/cm2), the overall transmission of the 
optics (20%), and the diameter and the field of view of 
the endoscope's objective (300 lxm and 75 ~ respec- 
tively) are known, the tissue autofluorescence yi ld can 
be evaluated. This estimate leads to the value of 10 -3 
autofluorescence photons emitted by the tissue per ex- 
citation photon at 514 urn. 
In conclusion, our preliminary study showed that a 
tissue differentiation can be performed on the basis of 
tissue autofluorescence only using a fluorescence life- 
time imaging technique. Moreover, we have shown that 
such endoscopic tissue characterization can be per- 
formed in quasi-real time (several refreshes per second) 
by detecting the optimal number of three phase-resolved 
fluorescence images. 
The experience gained in this study will help in the 
design of FLIM apparatuses for endoscopic diagnosis. 
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